Advocates on all sides of the breast screening debate are agreed that the earlier a malignant tumour is detected, the […]
Advocates on all sides of the breast screening debate are agreed that the earlier a malignant tumour is detected, the […]
This past week has been particularly busy for the field of artificial intelligence (AI). An open letter from Future of Life Institute […]
Twelve years ago, the FDA approved Hologic’s digital breast tomosynthesis (DBT) system – sometimes incorrectly referred to as 3D mammography – as […]
As we have previously reported, “dense breasts” refers to breasts that are composed of a greater proportion of fibrous and glandular […]
In a long-anticipated move, this past Wednesday GE spun out its healthcare division with a listing on the NASDAQ stock exchange. After […]
Eleven years ago, we reviewed the Pulitzer Prize-winning book, The Emperor of All Maladies: A Biography of Cancer, by oncologist Dr Siddhartha Mukherjee (© […]
Digital breast tomosynthesis (DBT) was approved by the FDA in 2011 as a screening modality for the early detection of […]
On Wednesday this week, Hologic released its second annual global women’s health index (GWHI), which provides a framework for achieving comprehensive progress. […]
The European Innovation Council, under the umbrella of its Pathfinder Programme, has recently awarded a grant of €2.7 million to a […]
Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]